NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

7.300.000.00%
The 2 analysts offering 1 year price forecasts for NBY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to NBY in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NBY EPS for the last quarter is −1.37 USD despite the estimation of −1.23 USD. In the next quarter EPS is expected to reach −0.31 USD. Track more of NovaBay Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter NovaBay Pharmaceuticals, Inc. revenue is expected to reach ‪2.60 M‬ USD. Check out NovaBay Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, NBY price target is 7.30 USD with a max estimate of 8.00 USD and a min estimate of 6.60 USD. Check if this forecast comes true in a year, meanwhile watch NovaBay Pharmaceuticals, Inc. stock price chart and keep track of the current situation with NBY news and stock market news.